Relmada Therapeutics, Inc. Presentations, Reports & Documents

Relmada Therapeutics 2022 Earnings Call REL-1017 Results

13 Pages

Relmada Therapeutics CNS Treatment 2024 Investor Presentation

Your message matters.

Let us design a presentation that delivers.

investor_presentation

41 Pages

Relmada Therapeutics Investor Presentation — June 2021

28 Pages

Relmada Therapeutics Investor Presentation — March 2022

34 Pages

Relmada Therapeutics Investor Presentation — May 2022

34 Pages

We turn ideas into stunning slides.